| Dr Mark Fleckner, MD,PC | |
|
520 Franklin Ave, Suite L6, Garden City, NY 11530 | |
| (516) 739-5905 | |
| (516) 739-6876 |
| Full Name | Dr Mark Fleckner |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 520 Franklin Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225063274 | NPI | - | NPPES |
| 02059149 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 200481 (New York) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 200481 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center | Rockville centre, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mark Fleckner M.d., P.c. | 0446359616 | 2 |
News Archive
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Kaiser Health News staff writer Mary Agnes Carey talks with first term Rep. Gerry Connolly, D-Va., who says the health care debate has changed dramatically since the combative town hall meetings of last August when some protesters across the country said passage of sweeping overhaul legislation would amount to a government takeover of the health care system (Carey, 8/25).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
Results of high-quality randomized clinical trials have determined that milk thistle extract, a widely used alternative medication, may not have any significant influence on the course of patients with alcoholic liver disease or hepatitis B or C liver disease.
› Verified 5 days ago
| Entity Name | Mark Fleckner M.d., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285850693 PECOS PAC ID: 0446359616 Enrollment ID: O20070628000624 |
News Archive
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Kaiser Health News staff writer Mary Agnes Carey talks with first term Rep. Gerry Connolly, D-Va., who says the health care debate has changed dramatically since the combative town hall meetings of last August when some protesters across the country said passage of sweeping overhaul legislation would amount to a government takeover of the health care system (Carey, 8/25).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
Results of high-quality randomized clinical trials have determined that milk thistle extract, a widely used alternative medication, may not have any significant influence on the course of patients with alcoholic liver disease or hepatitis B or C liver disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Fleckner, MD,PC 520 Franklin Ave, Suite L6, Garden City, NY 11530-5801 Ph: (516) 739-5905 | Dr Mark Fleckner, MD,PC 520 Franklin Ave, Suite L6, Garden City, NY 11530 Ph: (516) 739-5905 |
News Archive
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Kaiser Health News staff writer Mary Agnes Carey talks with first term Rep. Gerry Connolly, D-Va., who says the health care debate has changed dramatically since the combative town hall meetings of last August when some protesters across the country said passage of sweeping overhaul legislation would amount to a government takeover of the health care system (Carey, 8/25).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
Results of high-quality randomized clinical trials have determined that milk thistle extract, a widely used alternative medication, may not have any significant influence on the course of patients with alcoholic liver disease or hepatitis B or C liver disease.
› Verified 5 days ago
Di Zhou, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 450 Endo Blvd, Garden City, NY 11530 Phone: 516-832-8000 Fax: 516-683-3386 | |
Dr. Marilyn Ogrady, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 111 7th St, Garden City, NY 11530 Phone: 516-747-3349 Fax: 516-747-6003 | |
Thierry John Hufnagel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 450 Endo Blvd, Garden City, NY 11530 Phone: 516-832-8000 Fax: 516-832-8379 | |
Dr. Antonio Vinals, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 157 Meadow St, Garden City, NY 11530 Phone: 646-736-7324 Fax: 516-742-8364 | |
Rebecca Stein, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 711 Stewart Ave Ste 160, Garden City, NY 11530 Phone: 516-500-4200 | |
Joseph Younger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 520 Franklin Ave, Ste 101, Garden City, NY 11530 Phone: 516-741-4488 Fax: 516-741-2437 |